0001104659-22-049156.txt : 20220422 0001104659-22-049156.hdr.sgml : 20220422 20220422203104 ACCESSION NUMBER: 0001104659-22-049156 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220101 FILED AS OF DATE: 20220422 DATE AS OF CHANGE: 20220422 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oliviero James F III CENTRAL INDEX KEY: 0001434718 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38128 FILM NUMBER: 22847150 MAIL ADDRESS: STREET 1: C/O KERYX BIOPHARMACEUTICALS, INC. STREET 2: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc. CENTRAL INDEX KEY: 0001651407 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472568632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 212-554-4366 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 4 1 tm2213359-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-01-01 0 0001651407 Checkpoint Therapeutics, Inc. CKPT 0001434718 Oliviero James F III 95 SAWYER RD, SUITE 110 WALTHAM MA 02453 1 1 0 0 CEO, President and Director COMMON STOCK 2022-01-01 4 F 0 302777 3.11 D 3305433 D COMMON STOCK 2022-01-06 4 F 0 53024 2.77 D 3252409 D COMMON STOCK 2022-01-24 4 F 0 143136 2.19 D 3109273 D COMMON STOCK 2022-01-30 4 F 0 31972 2.46 D 3077301 D COMMON STOCK 2022-02-24 4 F 0 117657 1.85 D 2959644 D COMMON STOCK 2022-04-04 4 S 0 86353 1.79 D 2873291 D COMMON STOCK 2022-04-05 4 S 0 14030 1.77 D 2859261 D COMMON STOCK 2022-04-13 4 S 0 21258 1.51 D 2838003 D Consists of shares withheld by the Issuer with respect to the reporting person's tax withholding obligations upon the vesting and delivery of shares of common stock underlying restricted stock units previously granted by the issuer. Includes shares of restricted Common Stock, which vest over various time periods. Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.77 to $1.81. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.75 to $1.78. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.51 to $1.52. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. /s/ James F. Oliviero, III 2022-04-22